2008
DOI: 10.1016/j.schres.2007.12.469
|View full text |Cite
|
Sign up to set email alerts
|

The validity of Psychosis Proneness Scales as vulnerability indicators in recent-onset schizophrenia patients

Abstract: The Psychosis Proneness Scales developed by the Chapmans and colleagues (Chapman et al., 1995) are widely used to identify nonpatient individuals who are hypothesized to possess heightened vulnerability to schizophrenia and related psychopathology. Yet surprisingly little is known about whether schizophrenia patients themselves show abnormalities on these scales across different clinical states, as would be expected for vulnerability indicators. Scores on four of the Psychosis Proneness Scales were evaluated a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
40
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(41 citation statements)
references
References 57 publications
(89 reference statements)
1
40
0
Order By: Relevance
“…The use of a questionnaire measure, in form of the Paranoia Checklist to assess vulnerability to psychosis appears justifiable because attenuated subthreshold psychotic symptoms have been found to be risk factors, emerging before first episodes (Horan et al 2008) and are frequently used as a low level criterion in high-risk studies (Yung et al 2003).…”
Section: Discussionmentioning
confidence: 99%
“…The use of a questionnaire measure, in form of the Paranoia Checklist to assess vulnerability to psychosis appears justifiable because attenuated subthreshold psychotic symptoms have been found to be risk factors, emerging before first episodes (Horan et al 2008) and are frequently used as a low level criterion in high-risk studies (Yung et al 2003).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, while schizotypy has come to imply a multidimensional neurodevelopmental and psychopathological vulnerability to schizophrenia, schizotypal personality disorder reflects a nosological category of an Axis II diagnosis within the schizophrenia spectrum disorders (Kwapil and Barrantes-Vidal, 2012). Assuming that schizotypal personality disorder might represent not only a categorical diagnostic realm but also a key multidimensional psychopathological construct, schizotypal personality features may be potential vulnerability indicators for schizophrenia and psychosis (Horan et al, 2008). In this regard, several studies have provided interesting data on schizotypal phenomenology complex relationship with psychosis.…”
Section: Introductionmentioning
confidence: 99%
“…Following Nuechterlein and Dawson (1984) a valid and reliable candidate indicator of vulnerability to psychotic disorders should show evidence of a clear abnormality as compared to the general population, and that the abnormality itself be an enduring feature regardless of patients clinical status. In addition, the pattern of variation in severity of the abnormality in relation to the level of variation in symptoms over the course of the psychotic illness is essential to differentiate between stable, mediating and episoderelated vulnerability markers (independent, partially dependent and dependent on the acute symptomatology, respectively) (Horan et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Positive schizotypy refers to traits such as odd beliefs and perceptual disturbances that are similar to positive symptoms in schizophrenia, however, these symptoms are not as profound as those found in individuals with schizophrenia (Meehl, 1962;Raine, 2006). Several authors supported the notion that psychometric measures of schizotypy including the positive symptoms scale of the Schizotypal Personality Questionnaire (SPQ; Raine, 1991) indicate vulnerability to schizophrenia and related psychopathology (Barrantes-Vidal et al, 2013;Chapman, Chapman, Kwapil, Eckblad, & Zinser, 1994;Gooding, Tallent, & Matts, 2005;Horan, Reise, Subotnik, Ventura, & Nuechterlein, 2008;Lenzenweger & Loranger, 1989;Vollema, Sitskoorn, Apples, & Kahn, 2002). Research with individuals at risk avoids many confounds associated with chronic schizophrenia such as effects of medication, institutionalization, and changes related to illness duration, and helps identify traits that may be part of the liability to the disorder (Phillips & Seidman, 2008).…”
Section: Introductionmentioning
confidence: 99%